*ST赛隆: 独立董事提名人声明与承诺（王淑芳）

Core Viewpoint - The independent director candidate Wang Shufang has been nominated for the fourth board of directors of Sailong Pharmaceutical Group Co., Ltd. by Hainan Yayi Win-Win Technology Partnership (Limited Partnership) [1] Group 1: Nomination Process - The nomination was made after a thorough understanding of the candidate's professional background, education, qualifications, work experience, and any significant dishonesty records [1] - The candidate has agreed in writing to serve as an independent director [1] Group 2: Compliance with Regulations - The candidate has passed the qualification review by the nomination committee of the board of directors [2] - The candidate meets the qualifications and conditions for independent directors as stipulated by the China Securities Regulatory Commission and Shenzhen Stock Exchange [2][3] - The candidate has participated in training and obtained relevant certification recognized by the stock exchange [5] Group 3: Independence and Conflict of Interest - The candidate does not have any relationships that could affect their independent performance [1][2] - The candidate and their immediate family members do not hold more than 1% of the company's issued shares [5][6] - The candidate has no significant business dealings with the company or its controlling shareholders [6][7] Group 4: Professional Experience and Knowledge - The candidate possesses basic knowledge related to the operation of listed companies and has over five years of relevant work experience in law, economics, management, accounting, or finance [5][6] - If nominated as an accounting professional, the candidate must have at least a CPA qualification or equivalent advanced degree [5] Group 5: Commitment and Accountability - The nominator guarantees the truthfulness and completeness of the statements made in the nomination [9] - The nominator authorizes the company secretary to submit the declaration to the Shenzhen Stock Exchange [9]